PP
MRNA icon

PrairieView Partners’s Moderna MRNA Stock Holding History

PrairieView Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-175
Closed -$18K – 401
2023
Q3 		$18K Hold
175
– – ﹤0.01% 249
2023
Q2 		$21K Buy
+175
New +$23.3K ﹤0.01% 264
2022
Q2 		– Sell
-300
Closed -$52K – 470
2022
Q1 		$52K Hold
300
– – 0.01% 199
2021
Q4 		$76K Hold
300
– – 0.01% 175
2021
Q3 		$115K Hold
300
– – 0.02% 128
2021
Q2 		$70K Buy
+300
New +$53.6K 0.01% 148
2021
Q1 		– Sell
-833
Closed -$87K – 371
2020
Q4 		$87K Buy
+833
New +$84.3K 0.02% 125

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PrairieView Partners's MRNA Position: Q4 2023 in Review

PrairieView Partners sold out of Moderna (MRNA) in Q4 2023, closing a stake of 175 shares — an estimated $18K sold.

PrairieView Partners first reported a position in MRNA in Q4 2020 and held it in 7 quarters. The position peaked at $115K in Q3 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • PrairieView Partners reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • PrairieView Partners sold 175 Moderna shares in Q4 2023, an estimated $18K.
  • PrairieView Partners first reported a position in Moderna in Q4 2020 and held it in 7 quarters.
  • PrairieView Partners's Moderna position peaked at $115K in Q3 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on PrairieView Partners's 13F filing for Q4 2023, filed 26 Jan 2024.